by admin | Jan 22, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By American Parkinson’s Association – Two new therapies are entering the final stages of clinical trials before potential FDA approval. One is a novel dopamine-based therapy for motor symptom management, and the other is a stem cell therapy poised to...
by admin | Jan 21, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Esra Öz – NewScientist – Immune cells are most commonly engineered to kill cancers, but now, scientists have shown the technique makes the gut lining of older mice resemble that of younger mice, raising hopes that the same approach could work in people...
by admin | Jan 20, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Chinese Academy of Sciences – SciTechDaily – A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced. Chinese scientists have...
by admin | Jan 19, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Julie Grisham – Memorial Sloan Kettering Cancer Center – When it comes to giving immunotherapy to people with the most common form of lymphoma, the time of day may make a difference, according to new research from Memorial Sloan Kettering Cancer Center...
by admin | Jan 16, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Charles Bankhead – MedPageToday – Long-term survival in the CARTITUDE-1 trial showed that almost half of patients remained, alive with a median overall survival (OS) of 60.7 months. Almost three-fourths of the survivors remained progression free, and...
